PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells (Q43872427)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2002

Language	Label	Description	Also known as
English	PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells	scientific article published in January 2002

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells (English)

1 reference

Europe PubMed Central

27 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Yves Rival

1

1 reference

Europe PubMed Central

27 November 2017

Nathalie Benéteau

2

1 reference

Europe PubMed Central

27 November 2017

Thierry Taillandier

3

1 reference

Europe PubMed Central

27 November 2017

Mylène Pezet

4

1 reference

Europe PubMed Central

27 November 2017

Elisabeth Dupont-Passelaigue

5

1 reference

Europe PubMed Central

27 November 2017

Jean François Patoiseau

6

1 reference

Europe PubMed Central

27 November 2017

Didier Junquéro

7

1 reference

Europe PubMed Central

27 November 2017

Francis C Colpaert

8

1 reference

Europe PubMed Central

27 November 2017

André Delhon

9

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

27 November 2017

European Journal of Pharmacology

1 reference

Europe PubMed Central

27 November 2017

435

1 reference

Europe PubMed Central

27 November 2017

2-3

1 reference

Europe PubMed Central

27 November 2017

143-151

1 reference

Europe PubMed Central

27 November 2017

In vitro model of angiogenesis using a human endothelium‐derived permanent cell line: Contributions of induced gene expression, G‐proteins, and integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Leukocyte adhesion molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Permanent cell line expressing human factor VIII-related antigen established by hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Ligands for peroxisome proliferator-activated receptor inhibit monocyte CCR2 expression stimulated by plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Peroxisome proliferator-activated receptor delta (PPARdelta )-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Monocyte chemoattractant protein-1 in human atheromatous plaques

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

IL-1beta-induced monocyte chemoattractant protein-1 gene expression in endothelial cells is blocked by proteasome inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Leucocyte endothelial cell adhesion: a study comparing human umbilical vein endothelial cells and the endothelial cell line EA-hy-926.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-kappa B mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Cyclopentenone prostaglandins-new allies in the war on inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

The PPARs: from orphan receptors to drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901589-8

7 January 2021

Identifiers

10.1016/S0014-2999(01)01589-8

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43872427&oldid=2105499809"